Skip to content

CDR

BioScrip posts 1Q revenue gain, net loss

BioScrip Inc. saw an uptick in revenue for its fiscal 2010 first quarter but recorded a net loss due mainly to costs from its recent acquisition of Critical Homecare Solutions (CHS). The retail and specialty pharmacy operator said Friday that sales for the quarter ended March 31 totaled $335.

Merck appoints Frazier as new president

Merck & Co. has named Kenneth Frazier as the pharmaceutical giant’s new president, taking over that post from chairman and chief executive officer Richard Clark. Merck said Wednesday that Clark will continue as chairman and CEO.

Mylan, Teva, Actavis launch generic versions of Flomax

Mylan Pharmaceuticals Inc., Actavis Inc. and Teva Pharmaceutical Industries Ltd. this week began shipping generic versions of the branded drug Flomax, for the treatment of enlarged prostate. Mylan and Teva said Wednesday they received final approval from the Food and Drug Administration for 0.

Shoppers Drug Mart sees 1Q sales, profit rise

Robust pharmacy and front-end business lifted revenue and earnings at Shoppers Drug Mart (SDM) for the fiscal 2010 first quarter. The Canadian drug store chain said Wednesday that for the first quarter ended March 27, sales rose 5.7% to $2.

April sales dip at Rite Aid

Rite Aid Corp. reported a dip in same-store sales for April after seeing improved results in the previous month. The drug store chain said Thursday that same-store sales for the four weeks ended April 24 fell 1% from a year earlier. The company had posted flat same-store results in March after

Burnett, Barshay honored at NACDS Annual Meeting

Costco Wholesale Corp. executive Charles Burnett and former Schering-Plough Consumer Health Care chairman Stanley Barshay received the chain drug industry’s highest honors last night at the 2010 National Association of Chain Drug Stores Annual Meeting.

Jean Coutu records gains in fourth quarter

The Jean Coutu Group posted increases in sales, earnings and operating results for its fiscal 2010 fourth quarter and full year. The Canadian drug store chain said Wednesday that sales for the fourth quarter ended Feb. 27 rose 4.9% year over year to $637 million (Canadian) from $607.2 million.

Nicorette mini lozenge makes debut

GlaxoSmithKline Consumer Healthcare has launched a Nicorette mini-sized anti-smoking lozenge, which is designed to dissolve up to three times faster than other stop-smoking lozenges.

Takeda ships Dexilant antacid

Takeda Pharmaceuticals North America Inc. has rolled out Dexilant (dexlansoprazole) delayed-release capsules, for the treatment of heartburn and related ailments, to pharmacies in the United States. Dexilant is available in 30 mg and 60 mg capsules, Takeda said Monday.